Page last updated: 2024-11-08

delta9-tetrahydrocannabinol hemisuccinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID9844696
MeSH IDM0197077

Synonyms (1)

Synonym
delta9-tetrahydrocannabinol hemisuccinate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Oral administration of delta-9-tetrahydrocannabinal (delta 9-THC) was shown to result in low and erratic bioavailability, while the drug showed no bioavailability from various suppository formulations."( Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
ElSohly, MA; Harland, EC; Hikal, AH; Jones, AB; Little, TL; Rider, JN; Stanford, DF; Walker, LA, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.14)18.2507
2000's8 (57.14)29.6817
2010's3 (21.43)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]